Amphastar Pharmaceuticals Inc Earnings

Amphastar Pharmaceuticals Inc’s revenue fell -4.38% since last year same period to $174.41Mn in the Q2 2025. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated 2.28% jump in its revenue since last 3-months.

Amphastar Pharmaceuticals Inc’s net profit fell -18.23% since last year same period to $31.03Mn in the Q2 2025. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated 22.72% jump in its net profits since last 3-months.

Amphastar Pharmaceuticals Inc’s net profit margin fell -14.49% since last year same period to 17.79% in the Q2 2025. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated 19.99% jump in its net profit margins since last 3-months.

Amphastar Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.82 - a 10.73% jump from last quarter’s estimates.

Amphastar Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.82.

Amphastar Pharmaceuticals Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Amphastar Pharmaceuticals Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.